Atopic dermatitis affects up to 20% of children and quite frequently persists in adulthood. Follow-up, treatment, and prevention of relapses have an impact on healthcare spending. The aim of this study was to assess the cost-effectiveness of different emollients prescribed for patients with atopic dermatitis in France. A 3-health state Markov model was designed, using French data for resource utilization, price and transition probabilities. The effects of the use of 5 different emollients (A, B, C, D, E) or no emollient were compared. The selected outcome was time (years) without flare-up (YWFU). The 5-year cost for emollient A is 1,575.64€, and the effectiveness is 3.89 YWFU. Strategy A is the most effective. Compared with treatment E, which was the least expensive emollient, A is more expensive (+481.84€) and more effective (0.082 YWFU). The incremental cost-effectiveness ratio is 5,877.48€/YWFU. In conclusion, treating atopic dermatitis with emollients is a cost-effective strategy.

Similar articles

Cost Effectiveness of Emollients in the Prevention of Relapses in Atopic Dermatitis.
Cabout E, Eymere S, Launois R, Aslanian F, Ta?eb C, Seité S. Cabout E, et al. Clin Cosmet Investig Dermatol. 2020 Dec 21;13:987-996. doi: 10.2147/CCID.S279233. eCollection 2020. Clin Cosmet Investig Dermatol. 2020. PMID: 33376376 Free PMC article.
Cost and effectiveness of prescribing emollient therapy for atopic eczema in UK primary care in children and adults: a large retrospective analysis of the Clinical Practice Research Datalink.
Moncrieff G, Lied-Lied A, Nelson G, Holy CE, Weinstein R, Wei D, Rowe S. Moncrieff G, et al. BMC Dermatol. 2018 Oct 29;18(1):9. doi: 10.1186/s12895-018-0076-y. BMC Dermatol. 2018. PMID: 30373584 Free PMC article.
Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
Zimmermann M, Rind D, Chapman R, Kumar V, Kahn S, Carlson J. Zimmermann M, et al. J Drugs Dermatol. 2018 Jul 1;17(7):750-756. J Drugs Dermatol. 2018. PMID: 30005097
The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P, Payne L. Garside R, et al. Health Technol Assess. 2005 Jul;9(29):iii, xi-xiii,1-230. doi: 10.3310/hta9290. Health Technol Assess. 2005. PMID: 16022804 Review.
Bath emollients for atopic eczema: why use them?
[No authors listed] [No authors listed] Drug Ther Bull. 2007 Oct;45(10):73-5. doi: 10.1136/dtb.2007.09.0015. Drug Ther Bull. 2007. PMID: 17928284 Review.

Cost-effectiveness of Emollients in the Prevention of Relapse among French Patients with Atopic Dermatitis

Abstract

Similar articles